Secondary-Type Mutations Do Not Impact the Favorable Outcome of NPM1-Mutated Acute Myeloid Leukemia Patients - Results from a Large Cohort of Intensively Treated Patients

被引：1

作者：

Bill, Marius ^{[1
]}

Eckardt, Jan-Niklas ^{[1
]}

Rausch, Christian ^{[2
]}

Metzeler, Klaus H. ^{[3
]}

Spiekermann, Karsten ^{[4
]}

Stasik, Sebastian ^{[5
]}

Sauer, Tim ^{[6
]}

Scholl, Sebastian ^{[7
]}

Hochhaus, Andreas ^{[8
]}

Crysandt, Martina ^{[9
,10
]}

Bruemmendorf, Tim H. ^{[10
]}

Krug, Utz ^{[11
]}

Woermann, Bernhard ^{[12
]}

Hiddemann, Wolfgang

Goerlich, Dennis ^{[13
]}

Sauerland, Maria Cristina ^{[13
]}

Steffen, Bjoern ^{[14
]}

Einsele, Hermann ^{[15
]}

Neubauer, Andreas ^{[16
]}

Burchert, Andreas ^{[17
]}

Schaefer-Eckart, Kerstin ^{[18
]}

Berdel, Wolfgang E. ^{[19
]}

Schliemann, Christoph ^{[20
]}

Krause, Stefan W. ^{[21
]}

Hanel, Mathias ^{[22
]}

Hanoun, Maher ^{[23
]}

Kaufmann, Martin ^{[24
]}

Fransecky, Lars ^{[25
]}

Braess, Jan ^{[26
]}

Ruhnke, Leo ^{[27
]}

Schetelig, Johannes ^{[28
,29
]}

Middeke, Jan Moritz ^{[1
]}

Serve, Hubert ^{[30
]}

Baldus, Claudia D. ^{[31
]}

Platzbecker, Uwe ^{[32
]}

Mueller-Tidow, Carsten

Bornhaeuser, Martin

Herold, Tobias ^{[33
]}

Thiede, Christian ^{[5
]}

Roellig, Christoph ^{[27
]}

机构：

[1] Tech Univ Dresden, Univ Hosp Carl Gustav Carus, Dept Internal Med 1, Dresden, Germany

[2] Ludwig Maximilians Univ Munchen, LMU Univ Hosp, Dept Med 3, Lab Leukemia Diagnost, Munich, Germany

[3] Univ Leipzig, Med Ctr, Dept Hematol Cellular Therapy Hemostaseol & Infec, Leipzig, Germany

[4] Ludwig Maximilians Univ Munchen, LMU Univ Hosp, Dept Med 3, Munich, Germany

[5] Tech Univ Dresden, Univ Hosp Carl Gustav Carus, Dept Internal Med 1, Dresden, Germany

[6] Heidelberg Univ Hosp, Heidelberg, Germany

[7] Jena Univ Hosp, Klin Innere Med 2, Jena, Germany

[8] Klin Innere Med II, Dept Hematol & Oncol, Jena, Germany

[9] Univ Hosp RWTH Aachen, Dept Hematol & Oncol, Aachen, Germany

[10] Ctr Integrated Oncol Aachen Bonn Cologne Duesseld, Aachen, Germany

[11] Hosp Leverkusen, Dept Med 3, Leverkusen, Germany

[12] Charite, Dept Hematol Oncol & Tumor Immunol, Berlin, Germany

[13] Univ Munster, Inst Biostat & Clin Res, Munster, Germany

[14] Univ Hosp Frankfurt, Dept Hematol & Oncol, Frankfurt, Germany

[15] Univ Hosp Wurzburg, Dept Internal Med 2, Wurzburg, Germany

[16] Phillips Univ Marburg, Dept Hematol Oncol & Immunol, Marburg, Germany

[17] Univ Klinikum Giessen & Marburg, Hamatol Onkol & Immunol, Marburg, Germany

[18] BMT Unit, Med Clin 2, Nurnberg, Germany

[19] Univ Hosp Muenster, Dept Med Hematol & Oncol A, Munster, Germany

[20] Univ Hosp Muenster, Dept Med Hematol Oncol & Pneumol A, Munster, Germany

[21] Univ Klinikum Erlangen, Erlangen, Germany

[22] Klinikum Chemnitz, Dept Internal Med 3, Chemnitz, Germany

[23] Univ Hosp Essen, Dept Hematol, Essen, Germany

[24] Robert Bosch Krankenhaus, Dept Hematol Oncol & Palliat Care, Stuttgart, Germany

[25] Univ Hosp Schleswig Holstein Campus Kiel, Dept Internal Med Hematol Oncol 2, Kiel, Germany

[26] Hosp Barmherzige Brueder Regensburg, Regensburg, Germany

[27] Univ Hosp Dresden, Dept Internal Med 1, Dresden, Germany

[28] Tech Univ Dresden, Dresden, Germany

[29] DKMS Grp gGmbH, Dresden, Germany

[30] Goethe Univ Hosp Frankfurt, Dept Internal Med Hematol & Oncol 2, Frankfurt, Germany

[31] Univ Hosp Schleswig Holstein, Dept Hematol & Oncol, Campus Kiel, Kiel, Germany

[32] Univ Leipzig, Med Ctr, Leipzig, Germany

[33] Ludwig Maximilians Univ Munchen, LMU Univ Hosp, Dept Med 3, Munich, Germany

来源：

BLOOD | 2023年 / 142卷

关键词：

D O I：

10.1182/blood-2023-186160

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页数：6

共 50 条

[1] Secondary-type mutations do not impact outcome in NPM1-mutated acute myeloid leukemia - implications for the European leukemia net risk classification
Eckardt, Jan-Niklas
Bill, Marius
Rausch, Christian
Metzeler, Klaus
Spiekermann, Karsten
Stasik, Sebastian
Sauer, Tim
Scholl, Sebastian
Hochhaus, Andreas
Crysandt, Martina
Bruemmendorf, Tim H.
Krug, Utz
Woermann, Bernhard
Hiddemann, Wolfgang
Goerlich, Dennis
Sauerland, Cristina
Steffen, Bjoern
Einsele, Hermann
Neubauer, Andreas
Burchert, Andreas
Schaefer-Eckart, Kerstin
Berdel, Wolfgang E.
Schliemann, Christoph
Krause, Stefan W.
Haenel, Mathias
Hanoun, Maher
Kaufmann, Martin
Fransecky, Lars
Braess, Jan
Ruhnke, Leo
Schetelig, Johannes
Middeke, Jan Moritz
Serve, Hubert
Baldus, Claudia D.
Platzbecker, Uwe
Mueller-Tidow, Carsten
Bornhaeuser, Martin
Herold, Tobias
Thiede, Christian
Roellig, Christoph
LEUKEMIA, 2023, 37 (11) : 2282 - 2285
[2] Secondary-type mutations do not impact outcome in NPM1-mutated acute myeloid leukemia – implications for the European LeukemiaNet risk classification
Jan-Niklas Eckardt
Marius Bill
Christian Rausch
Klaus Metzeler
Karsten Spiekermann
Sebastian Stasik
Tim Sauer
Sebastian Scholl
Andreas Hochhaus
Martina Crysandt
Tim H. Brümmendorf
Utz Krug
Bernhard Wörmann
Wolfgang Hiddemann
Dennis Görlich
Cristina Sauerland
Björn Steffen
Hermann Einsele
Andreas Neubauer
Andreas Burchert
Kerstin Schäfer-Eckart
Wolfgang E. Berdel
Christoph Schliemann
Stefan W. Krause
Mathias Hänel
Maher Hanoun
Martin Kaufmann
Lars Fransecky
Jan Braess
Leo Ruhnke
Johannes Schetelig
Jan Moritz Middeke
Hubert Serve
Claudia D. Baldus
Uwe Platzbecker
Carsten Müller-Tidow
Martin Bornhäuser
Tobias Herold
Christian Thiede
Christoph Röllig
Leukemia, 2023, 37 : 2282 - 2285
[3] Secondary-type mutations do not impact prognosis in acute myelogenous leukemia AML with mutated NPM1
Wright, Martha F.
Pozdnyakova, Olga
Hasserjian, Robert P.
Aggarwal, Nidhi
Shaver, Aaron C.
Weinberg, Olga K.
Irlmeier, Rebecca
Koyama, Tatsuki
Seegmiller, Adam C.
Strickland, Stephen A.
Mason, Emily F.
AMERICAN JOURNAL OF HEMATOLOGY, 2022, 97 (12) : E462 - E465
[4] NPM1 Mutations Are a Secondary Genetic Event in NPM1-Mutated Acute Myeloid Leukemia
Patel, Jay L.
Schumacher, Jonathan
Szankasi, Philippe
Frizzell, Kimberly
Sorrells, Shelly
Shen, Wei
Clayton, Adam
Jattani, Rakhi
Kelley, Todd W.
LABORATORY INVESTIGATION, 2017, 97 : 369A - 369A
[5] NPM1 Mutations Are a Secondary Genetic Event in NPM1-Mutated Acute Myeloid Leukemia
Patel, Jay L.
Schumacher, Jonathan
Szankasi, Philippe
Frizzell, Kimberly
Sorrells, Shelly
Shen, Wei
Clayton, Adam
Jattani, Rakhi
Kelley, Todd W.
MODERN PATHOLOGY, 2017, 30 : 369A - 369A
[6] Correction to "Secondary-Type Mutations Do Not Impact Prognosis in Acute Myelogenous Leukemia AML With Mutated NPM1"
Wright, M. F.
Pozdnyakova, O.
Hasserjian, R. P.
AMERICAN JOURNAL OF HEMATOLOGY, 2025, 100 (05) : 944 - 944
[7] Impact of additional genetic alterations on the outcome of patients with NPM1-mutated cytogenetically normal acute myeloid leukemia
Peterlin, Pierre
Renneville, Aline
Ben Abdelali, Raouf
Nibourel, Olivier
Thomas, Xavier
Pautas, Cecile
de Botton, Stephane
Raffoux, Emmanuel
Cayuela, Jean-Michel
Boissel, Nicolas
Terre, Christine
Celli-Lebras, Karine
Castaigne, Sylvie
Preudhomme, Claude
Gardin, Claude
Dombret, Herve
HAEMATOLOGICA, 2015, 100 (05) : e196 - e199
[8] Secondary-Type Mutations Do Not Impact Prognosis in AML with Mutated NPM1
Wright, Martha
Pozdnyakova, Olga
Hasserjian, Robert
Aggarwal, Nidhi
Shaver, Aaron
Weinberg, Olga
Seegmiller, Adam
Mason, Emily
LABORATORY INVESTIGATION, 2020, 100 (SUPPL 1) : 1409 - 1409
[9] Secondary-Type Mutations Do Not Impact Prognosis in AML with Mutated NPM1
Wright, Martha
Pozdnyakova, Olga
Hasserjian, Robert
Aggarwal, Nidhi
Shaver, Aaron
Weinberg, Olga
Seegmiller, Adam
Mason, Emily
MODERN PATHOLOGY, 2020, 33 (SUPPL 2) : 1409 - 1409
[10] Impact of myelodysplasia-related and additional gene mutations in intensively treated patients with NPM1-mutated AML
Cocciardi, Sibylle
Saadati, Maral
Weiss, Nina
Spaeth, Daniela
Kapp-Schwoerer, Silke
Schneider, Isabelle
Meid, Annika
Gaidzik, Verena I.
Skambraks, Sabrina
Fiedler, Walter
Kuehn, Michael W. M.
Germing, Ulrich
Mayer, Karin T.
Luebbert, Michael
Papaemmanuil, Elli
Thol, Felicitas
Heuser, Michael
Ganser, Arnold
Bullinger, Lars
Benner, Axel
Doehner, Hartmut
Doehner, Konstanze
HEMASPHERE, 2025, 9 (01):

← 1 2 3 4 5 →